Ninety-seven percent of elderly patients (over 85 years) treated in the ICU for circulatory failure die within 12 months of the life-threatening episode. The ICU survival rate is 33 % and about 23 % of patients are discharged from hospital, but only 8 % are alive at 6 months and only 3 % at 1 year.One cannot help but feel uncomfortable and discouraged after reading the results of a secondary analysis of data from a large trial comparing the effects of dopamine and noradrenaline on ICU outcomes by Biston et al. [1], in this issue of Intensive Care Medicine.What are the implications of taking into consideration the very uncertain prognosis associated with elderly patients treated in the ICU for circulatory failure? What is the appropriate clinical algorithm and how should a physician respond the next time a call comes in from an emergency department about an 85-year-old patient in shock?
Researcher vs. attending physician bias and potential conflict of interestWhen a study finds a 3 % survival and 97 % mortality rate, then the 3 % are often associated with an 'opportunity for improvement' and the 97 % is presented as a 'challenge.' Although it is an acceptable and motivating proposition for a researcher, the same terms 'opportunity' and 'challenge' can be viewed as unrealistic and misleading expressions relative to the real world of clinical decision-making and complex and unique patient-physician relationships.